$2.96
-0.06-1.99%
At Close: -
$2.98
0.020.68%
After Hours: 6:01 PM EDT
15 minutes delayed
Comments
Loading...
ZyVersa Therapeutics (ZVSA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestZyVersa Therapeutics (NASDAQ:ZVSA) Stock Quotes, Forecast and News Summary
ZyVersa Therapeutics Stock (NASDAQ: ZVSA) stock price, news, charts, stock research, profile.
| Open | $3.20 |
| Close | $2.96 |
| Volume / Avg. | 90.68K / 146.95K |
| Day Range | $2.84 - $3.23 |
| 52 Wk Range | 2.61 - 159.60 |
| Market Cap | $3.07M |
| P/E Ratio | 0.00 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 43 |
| Short Interest | 5.47% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About ZyVersa Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary techno...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy ZyVersa Therapeutics (ZVSA) stock?
You can purchase shares of ZyVersa Therapeutics (NASDAQ:ZVSA) through any online brokerage.
Who are ZyVersa Therapeutics (ZVSA) competitors?
Other companies in ZyVersa Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Dermata Therapeutics (NASDAQ:DRMA), Tharimmune (NASDAQ:THAR), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
What is the forecast, or price target, for ZyVersa Therapeutics (ZVSA) stock?
ZyVersa Therapeutics has a consensus price target of $12.00.
What is the current price for ZyVersa Therapeutics (ZVSA)?
The stock price for ZyVersa Therapeutics (NASDAQ: ZVSA) is $2.98 last updated August 23, 2024 at 6:01 PM EDT.
Does ZyVersa Therapeutics (ZVSA) pay a dividend?
There are no upcoming dividends for ZyVersa Therapeutics.
When is ZyVersa Therapeutics (NASDAQ:ZVSA) reporting earnings?
ZyVersa Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is ZyVersa Therapeutics (ZVSA) going to split?
There is no upcoming split for ZyVersa Therapeutics.
What sector and industry does ZyVersa Therapeutics (ZVSA) operate in?
ZyVersa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.